MTOR and cancer: Metformin LKB1 activation in human cancer cell lines in vitro is associated with inhibition of the mammalian target of rapamycine (mTOR), with subsequent reduced cellular proliferation (Shaw et al, 2004a, 2004b; Dowling et al, 2006; Zakikhani et al, 2006).